Slowing U.S. venture investment is spurring startups to consider investors from the oil-rich country. : Some biotechnology startups are raising capital from Saudi Arabia as U.S. venture funding retreats and Middle East countries seek to boost their life-sciences industries. Chicago-based Flashpoint Therapeutics recently raised seed financing led by Beta Lab, a new venture firm based in Riyadh, and biomedical startups including Insilico Medicine have secured funding from Prosperity7 Ventures, the venture fund of Aramco Ventures, a subsidiary of Saudi Arabia’s national oil company.